Patents-Review.com
🔗 Permalink
Assignee profile:

Abraxis BioScience, Inc.

City:

Los Angeles, California

Country:

United States

Published Applications:

21

Last publication date:

2011-08-11

Patent Grants:

12

Last grant date:

2010-10-26

Top Inventors for applications by Abraxis BioScience, Inc.

These are the the leading inventors for applications assigned to Abraxis BioScience, Inc.:

Recent patent applications by Abraxis BioScience, Inc.

Abraxis BioScience, Inc. based in Los Angeles, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-08-11
US20110196026A1
Human necessities

COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY

 #2 | 2010-09-09 ✅ Patent 7,820,788 granted on 2010-10-26
US20100226996A1
Human necessities

Compositions and methods of delivery of pharmacological agents

 #3 | 2010-06-24 ✅ Patent 8,026,275 granted on 2011-09-27
US20100160448A1
Human necessities

Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury

 #4 | 2009-11-26 ✅ Patent 8,415,304 granted on 2013-04-09
US20090291139A1
Physics

Sparc and methods of use thereof

 #5 | 2009-02-12 ✅ Patent 8,003,402 granted on 2011-08-23
US20090042303A1
Physics

Method for measuring the concentration of a glycosaminoglycan anticoagulant

 #6 | 2008-11-06 ✅ Patent 7,586,008 granted on 2009-09-08
US20080275100A1
Chemistry; metallurgy

Propofol analogs, process for their preparation, and methods of use

 #7 | 2008-10-16
US20080255035A1
Human necessities

SPARC AND METHODS OF USE THEREOF

 #8 | 2008-09-25 ✅ Patent 7,816,346 granted on 2010-10-19
US20080234246A1
Chemistry; metallurgy

Analogs of ansamycin and pharmaceutical compositions thereof

 #9 | 2008-07-31
US20080182258A1
Chemistry; metallurgy

Q3 SPARC DELETION MUTANT AND USES THEREOF

 #10 | 2008-07-24 ✅ Patent 7,858,782 granted on 2010-12-28
US20080176853A1
Chemistry; metallurgy

Triazine derivatives and their therapeutical applications

 #11 | 2008-07-17
US20080171687A1
Human necessities

Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs

 #12 | 2008-06-05
US20080132582A1
Human necessities

PROPOFOL FORMULATION CONTAINING REDUCED OIL AND SURFACTANTS

 #13 | 2007-09-06 ✅ Patent 7,795,266 granted on 2010-09-14
US20070208030A1
Human necessities

Tetrahydroindolone derivatives for treament of neurological conditions

 #14 | 2007-08-09
US20070185217A1
Chemistry; metallurgy

Propofol analogs, process for their preparation, and methods of use

 #15 | 2007-06-07
US20070129448A1
Human necessities

COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS

 #16 | 2007-06-07
US20070128290A1
Human necessities

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

 #17 | 2007-05-24 ✅ Patent 8,257,733 granted on 2012-09-04
US20070116774A1
Human necessities

Methods and compositions for treating proliferative diseases

 #18 | 2007-04-26
US20070092563A1
Human necessities

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

 #19 | 2007-04-19 ✅ Patent 8,137,684 granted on 2012-03-20
US20070087022A1
Human necessities

Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

 #20 | 2007-04-12 ✅ Patent 8,034,765 granted on 2011-10-11
US20070082838A1
Human necessities

Compositions and methods for preparation of poorly water soluble drugs with increased stability

 #21 | 2006-09-07 ✅ Patent 7,332,568 granted on 2008-02-19
US20060199248A1
Chemistry; metallurgy

Q3 SPARC deletion mutant and uses thereof
AssigneeID:

215712 ⎘